Patient allegedly received an implant on (b)(6) 2014 via right internal jugular vein due to deep vein thrombosis (dvt).Patient is vena cava perforation.The patient further alleges chest pain, nausea, lightheadedness and shortness of breath.Per a ct (computed tomography) scan of the abdomen dated (b)(6) 2017, ¿findings: an ivc filter is in place.The top apex of the filter is seen just below the level of the renal veins, with the apex posterior to the center of the ivc lumen.The prongs appear symmetric.The larger prongs at the 1:00 and 11 :00 positions appear to extend beyond the lumen approximately 1 and 2mm respectively.The other prongs does not appear to extend significantly beyond the lumen.There are no visible fractures or bending of the struts.No significant abnormal tilting is evident.There is no collapse of the ivc distal to the filter.¿.
|
Device code(s): appropriate term/code not available (3191) was selected for the alleged perforation.Investigation is reopened due to additional information provided.The following allegations have been investigated: vena cava perforation, chest pain, nausea, light headed, dyspnea.The reported allegations have been further investigated based on the information provided to date.Filter interacts with ivc wall, e.G.Penetration/perforation/embedment.This may be either symptomatic or asymptomatic.Potential causes may include improper deployment; and (or) excessive force or manipulations near an in-situ filter (e.G., a surgical or endovascular procedure in the vicinity of a filter).Potential adverse events that may occur include, but are not limited to, the following: trauma to adjacent structures, vascular trauma, vena cava perforation, vena cava penetration.Unknown if the reported chest pain, nausea, lightheaded, dyspnea are directly related to the filter and unable to identify a corresponding failure mode at this point in time.Catalog and lot numbers are unknown, however, the alleged celect is manufactured and inspected according to current controls.No evidence to suggest that this device was not manufactured according to specifications and nothing indicates that the filter did not perform as intended, e.G.Intended for the prevention of recurrent pulmonary embolism (pe) via placement in the vena cava.Cook will reopen its investigation if further information is received warranting supplementation in accordance with 21 c.F.R.803.56.This report includes information known at this time.A follow-up medwatch report will be submitted if additional relevant information becomes available.This report is required by the fda under 21 cfr part 803.This report is based on unconfirmed information submitted by others.Neither the submission of this report nor any statement made in it is intended to be an admission that any cook device is defective or malfunctioned, that a death or serious injury occurred, or that any cook device caused or contributed to or is likely to cause or contribute to a death or serious injury if a malfunction occurred.
|